ALP-1

· Biopeutics Co., Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ALP-1, covering 2025-12-15 to 2025-12-15. Get the full timeline:

Most recent: Clinical Trial Update: ALP-1 Continuous Intravenous Infusion to Maintain Clinical Stability in Advanced Heart Failure [Phase 3]